Literature DB >> 15616019

Nuclear factor-{kappa}B activity in {beta}-cells is required for glucose-stimulated insulin secretion.

Stefan Norlin1, Ulf Ahlgren, Helena Edlund.   

Abstract

Glucose-stimulated insulin secretion (GSIS) in pancreatic beta-cells depends on coordinated glucose uptake, oxidative metabolism, and Ca(2+)-triggered insulin exocytosis. Impaired GSIS is a hallmark of type 2 diabetes. However, at present we know very little about the molecular mechanisms that induce and maintain the expression of genes required for GSIS in beta-cells. The transcription factor nuclear factor-kappaB (NF-kappaB) is activated by an increase in intracellular Ca(2+) in beta-cells. Here, we show that attenuation of NF-kappaB activation in beta-cells generates mice with impaired GSIS, and that the beta-cells show perturbed expression of genes required for glucose uptake, oxidative metabolism, and insulin exocytosis. Thus, NF-kappaB appears to be part of a positive regulatory circuit that maintains GSIS in pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15616019     DOI: 10.2337/diabetes.54.1.125

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  44 in total

1.  Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.

Authors:  R Eldor; A Yeffet; K Baum; V Doviner; D Amar; Y Ben-Neriah; G Christofori; A Peled; J C Carel; C Boitard; T Klein; P Serup; D L Eizirik; D Melloul
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-21       Impact factor: 11.205

2.  Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus.

Authors:  Nasim Samandari; Aashiq H Mirza; Lotte B Nielsen; Simranjeet Kaur; Philip Hougaard; Siri Fredheim; Henrik B Mortensen; Flemming Pociot
Journal:  Diabetologia       Date:  2016-11-19       Impact factor: 10.122

3.  Involvement of long non-coding RNAs in beta cell failure at the onset of type 1 diabetes in NOD mice.

Authors:  Anna Motterle; Sonia Gattesco; Dorothée Caille; Paolo Meda; Romano Regazzi
Journal:  Diabetologia       Date:  2015-06-03       Impact factor: 10.122

4.  Conditional and specific inhibition of NF-κB in mouse pancreatic β cells prevents cytokine-induced deleterious effects and improves islet survival posttransplant.

Authors:  Jonathan S Rink; Xiaojuan Chen; Xiaomin Zhang; Dixon B Kaufman
Journal:  Surgery       Date:  2011-10-06       Impact factor: 3.982

Review 5.  Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.

Authors:  Zhuo Fu; Elizabeth R Gilbert; Dongmin Liu
Journal:  Curr Diabetes Rev       Date:  2013-01-01

6.  IKKβ inhibition prevents fat-induced beta cell dysfunction in vitro and in vivo in rodents.

Authors:  Aleksandar Ivovic; Andrei I Oprescu; Khajag Koulajian; Yusaku Mori; Judith A Eversley; Liling Zhang; Rodolfo Nino-Fong; Gary F Lewis; Marc Y Donath; Michael Karin; Michael B Wheeler; Jan Ehses; Allen Volchuk; Catherine B Chan; Adria Giacca
Journal:  Diabetologia       Date:  2017-07-20       Impact factor: 10.122

7.  [Update on type 1 diabetes].

Authors:  I Heukamp; C Then; A Lechner; J Seissler
Journal:  Internist (Berl)       Date:  2013-02       Impact factor: 0.743

8.  Mitochondrial Ca2+, the secret behind the function of uncoupling proteins 2 and 3?

Authors:  Wolfgang F Graier; Michael Trenker; Roland Malli
Journal:  Cell Calcium       Date:  2008-02-20       Impact factor: 6.817

9.  Expression of the NH(2)-terminal fragment of RasGAP in pancreatic beta-cells increases their resistance to stresses and protects mice from diabetes.

Authors:  Jiang-Yan Yang; Jöel Walicki; Evrim Jaccard; Gilles Dubuis; Natasa Bulat; Jean-Pierre Hornung; Bernard Thorens; Christian Widmann
Journal:  Diabetes       Date:  2009-08-20       Impact factor: 9.461

10.  Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.

Authors:  Elodie Roggli; Aurore Britan; Sonia Gattesco; Nathalie Lin-Marq; Amar Abderrahmani; Paolo Meda; Romano Regazzi
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.